Skip to content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
Get the latest shareable resources on coping with COVID-19 from NIMH: https://www.nimh.nih.gov/covid19

Director’s Messages about Treatments

A Plan for Mental Health Research

By Joshua Gordon on

This week, the National Institute of Mental Health unveiled its new NIMH Strategic Plan for Research. In this Director’s message, Dr. Gordon discusses the advances in knowledge and treatment that got us to where we are today and points to where we want our research to go in the future.

Read More

Addressing Disparities: Advancing Mental Health Care for All Americans

By Joshua Gordon on

Mental health disparities are significant and easily documented. In this Director’s Message, Dr. Gordon discusses NIMH-funded research that aims to close the gap, ensuring that improved mental health care meets the needs of all Americans.

Read More

Suicide Deaths Are a Major Component of the Opioid Crisis that Must Be Addressed

By Joshua Gordon , Nora Volkow on

September is National Suicide Prevention Awareness Month. In observance, Dr. Gordon has partnered with Dr. Volkow, Director of the National Institute on Drug Abuse (NIDA), to highlight a dimension of the opioid crisis that receives too little attention—the links between opioid use, opioid use disorder, and suicide.

Read More

New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine

By Joshua Gordon on

In his latest message, Dr. Gordon discusses the role of NIMH and other researchers in the development of esketamine, an FDA-approved, rapid-acting medication that targets treatment-resistant depression.

Read More

I’m Optimistic about Depression

By Joshua Gordon on

In this Director’s Message, Dr. Gordon discusses research-based advances in the understanding and treatment of depression.

Read More

A Bench-to-Bedside Story: The Development of a Treatment for Postpartum Depression

By Joshua Gordon on

In this message, Dr. Gordon discusses the role of NIMH and others in the bench-to-bedside story of brexanolone, which has just been approved by the FDA as the first treatment specifically for postpartum depression. 

Read More

NIMH and the NIH HEAL Initiative: Collaborating to address the opioid epidemic

By Joshua Gordon on

Dr. Gordon discusses NIMH’s role in The Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM, the National Institutes of Health’s (NIH) all-in, coordinated response to the opioid epidemic.

Read More

Translational Research: From Research Findings to Transformative Treatments

By Joshua Gordon on

The American College of Neuropsychopharmacology (ACNP) focuses on research which translates basic neuroscience findings into novel treatments. In this Director’s Message, Dr. Gordon discusses some of the exciting work presented at this year’s ACNP meeting.

Read More

On Being Ill

By Joshua Gordon on

After an emergency room visit on Thanksgiving, Dr. Gordon reflects on treatments for injury vs. psychiatric conditions.

Read More

An Experimental Therapeutic Approach to Psychosocial Interventions

By Joshua Gordon on

Dr. Gordon talks about NIMH’s commitment to support the development and testing of psychosocial interventions in the greater context of the experimental therapeutics approach to treatment research.

Read More